Showing results (281-290 of 15,737) with videos related to
Sort By:
Pageof 1,574
The Journal of Antimicrobial Chemotherapy|January 3, 2012
Pan-European monitoring of susceptibility to human-use antimicrobial agents in enteric bacteria isolated from healthy food-producing animalsAnno de Jong, Valérie Thomas, Shabbir Simjee, et al.The Journal of Antimicrobial Chemotherapy|December 17, 2011
A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycinNimish Patel, Hillary VanDeWall, Linda Tristani, et al.The Journal of Antimicrobial Chemotherapy|December 22, 2011
The TCA cycle is not required for selection or survival of multidrug-resistant SalmonellaVito Ricci, Nick Loman, Mark Pallen, et al.The Journal of Antimicrobial Chemotherapy|December 22, 2011
Antibiotic prophylaxis for cardiac surgeryRuth Kappeler, Margaret Gillham, Nicholas M BrownThe Journal of Antimicrobial Chemotherapy|May 1, 1990
The influence of human monocytes on the antibacterial activity of vancomycin and teicoplanin against Staphylococcus aureusP J van der Broek, L F BuysThe Journal of Antimicrobial Chemotherapy|April 5, 2011
Change in antipseudomonal carbapenem susceptibility in 25 hospitals across 9 years is not associated with the use of ertapenemKathryn J Eagye, David P NicolauThe Journal of Antimicrobial Chemotherapy|April 22, 2011
Clinical epidemiology of carbapenem-intermediate or -resistant EnterobacteriaceaeNimish Patel, Susan Harrington, Amanda Dihmess, et al.The Journal of Antimicrobial Chemotherapy|April 22, 2011
Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetrationAurélie Fayet Mello, Thierry Buclin, Claudia Franc, et al.The Journal of Antimicrobial Chemotherapy|April 9, 2011
Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patientsIsabelle Malet, Marc Wirden, Slim Fourati, et al.The Journal of Antimicrobial Chemotherapy|April 23, 2011
In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzaeTakafumi Sato, Yui Kawai, Hayato Matsuda, et al.Pageof 1,574